Celldex Therapeutics, Inc. Share Price Nasdaq
Equities
US15117B1035
Biotechnology & Medical Research
Sales 2024 * | 3.39M 282M | Sales 2025 * | 3.13M 261M | Capitalization | 2.39B 200B |
---|---|---|---|---|---|
Net income 2024 * | -170M -14.18B | Net income 2025 * | -203M -16.94B | EV / Sales 2024 * | 622 x |
Net cash position 2024 * | 285M 23.8B | Net cash position 2025 * | 372M 31.08B | EV / Sales 2025 * | 646 x |
P/E ratio 2024 * |
-12.5
x | P/E ratio 2025 * |
-11.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 101.99% |
Latest transcript on Celldex Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 01/83/01 |
Anthony Marucci
FOU | Founder | 62 | 01/83/01 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 01/09/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 01/08/01 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 16/22/16 |
Harry H. Penner
BRD | Director/Board Member | 78 | 01/97/01 |
1st Jan change | Capi. | |
---|---|---|
+2.30% | 42.75B | |
+47.81% | 41.61B | |
+11.44% | 41.34B | |
-12.36% | 26.59B | |
+8.25% | 25.49B | |
-24.25% | 18.12B | |
+30.08% | 12.24B | |
-1.84% | 11.76B | |
+7.59% | 11B |